BNT162b2 mRNA COVID-19 Vaccine: First Approval
BNT162b2 mRNA COVID-19 백신: 첫 번째 승인
Review
[키워드] active immunization
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Administered
age
Antigen
approval
approvals
Bahrain
BNT162b2
BNT162b2 mRNA
Canada
caused
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
elicit
Emergency use
Emergency use authorization
ENCODE
EUA
expression
immune response
immune responses
immunization
individual
Infection
intramuscularly
Novel coronavirus
novel coronavirus disease
nucleoside
nucleoside-modified mRNA
of BNT162b2
Older
Pfizer
Prevent
prevention of COVID-19
recipients
respiratory
SARS-CoV-2
SARS-CoV-2 spike protein
Saudi Arabia
severe acute respiratory syndrome Coronavirus
Spike protein
Switzerland
the SARS-CoV-2
two-dose regimen
USA
Vaccine
[DOI] 10.1007/s40265-021-01480-7 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s40265-021-01480-7 PMC 바로가기 [Article Type] Review